Rapid diagnostic tests based on paper microfluidics
Paperdrop Diagnostics S.L. develops rapid diagnostic tests based on paper microfluidics, dealing with non-covered medical needs and emerging health problems, with special interest in critical and prevalent diseases. Our technology is based on lateral flow immunoassays, similar to pregnancy tests, which are being optimized to act as a clinical decision tool. A single drop of patient’s fluid (e.g. blood) is required to carry out the test using a paper sensor. It is a low-cost and easy-to-use tool that presents improved sensitivity and specificity than current lab tests.
No need of any equipment, just a device as simple as a pregnancy test and one drop of sample.
Molecular and genetic biomarkers along with new signal detection and visualization strategies.
Paper has unlimited capacities, is easy to be manufactured and is totally reciclable.
Fast & Easy
Just one drop on the paper, wait about 5 minutes and that’s it: the diagnostic is done.
Antimicrobial Resistance (AMR) is a growing threat to public health as bacteria and fungi become resistant to drugs. Without action, deaths could reach 10M annually by 2050. Urgent, affordable monitoring tools are crucial, and the EU’s One Health Action Plan seeks to combat AMR through enhanced surveillance, responsible antibiotic use, and research into new treatments.
In this context, PaperdropDx has developed ResistgeneTM a revolutionary assay that offers a near-patient testing solution for detecting multiple AMR genes focusing on carbapenemases, a critical resistance mechanism.